All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Promore Pharma AB, of Stockholm, filed a phase III trial application involving its most advanced asset, PXL01, for prevention of post-surgical adhesions after tendon repair surgery in the hand.